brief report Clinical Evaluation of the Efficacy and Tolerability of Fitostimoline® Plus Cream Following Laser Therapy, DTC or Cryotherapy: Case Series
Authors: Stefano Veraldi*
*Corresponding Author: Stefano Veraldi, Dermatology Unit, University of Milan, Italy
Received Date: 28 February, 2022
Accepted Date: 28 February, 2022
Published Date: 28 February 2022
Citation: Veraldi S (2022) Clinical Evaluation of the Efficacy and Tolerability of Fitostimoline® Plus Cream Following Laser Therapy, DTC or Cryotherapy: Case Series. Clin Exp Dermatol Ther 7: 174.DOI: https://doi.org/10.29011/2575-8268.100174
Fitostimoline® plus cream is a medical device consisting of Rigenase® and polyhexanide. It is used for the treatment of lesions of various etiologies at risk of bacterial superinfections.
Rigenase® is a wheat extract with antioxidant and moisturizing properties. Polyhexanide is an antiseptic for which bacterial resistance has not been reported to date in vitro and in vivo.
The device was used in 88 patients (50 males and 38 females, aged between 18 and 91 years) with skin lesions of various kinds, such as seborrheic keratoses, ruby haemangiomas, fibromas, actinic keratoses) treated with laser therapy or electrodesiccation or cryotherapy. The product was applied twice a day for 5 days.
No bacterial superinfection was observed clinically.
The results obtained with this experience allow us to conclude that the product under examination can be successfully used for the prevention of bacterial superinfections after treatments with laser, electrodesiccation or cryotherapy.